Compare Becton Dickinson and Co (BDX) vs GXO Logistics Inc (GXO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs GXO Logistics Inc — how do they compare? Becton Dickinson and Co trades at $155 (market cap $41.51B), while GXO Logistics Inc trades at $52 (market cap $5.71B). The key difference: Becton Dickinson and Co is far larger — about 7.3× GXO Logistics Inc's market cap, and Becton Dickinson and Co pays a 2.79% dividend while GXO Logistics Inc pays none. Which is the better fit depends on your goals.
| BDX | GXO | |
|---|---|---|
Market Cap | $41.51B | $5.71B |
Sector | Health | Industrials |
52-Week High | $185.39 | $65.59 |
52-Week Low | $135.49 | $45.52 |
Enterprise Value | $57.97B | $10.88B |
Dividend Yield | 2.79% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX trades at $153.83, up 1.24% today, with technical indicators showing a neutral to bullish bias. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $2.90 exceeding expectations. Revenue growth remains steady, reaching $21.84B in 2025, though net margins have compressed to 5.12%. Recent news highlights BDX's innovation in medical technology and positive analyst sentiment.
The outlook for BDX appears balanced. Upside potential exists from continued earnings beats and strategic positioning in growing healthcare segments like GLP-1 drug support equipment. However, risks include margin pressure, elevated debt levels, and cautious hospital spending. The consensus price target of $173.40 suggests moderate upside from current levels.
GXO Logistics trades at $48.99, down 3.2% today, with a bearish technical outlook despite strong analyst support. The company shows solid revenue growth with Q1 2026 earnings beating expectations at $0.50 per share versus $0.37 expected. Recent partnerships with major retailers and expansion in Europe highlight business momentum, though thin profit margins and competitive pressures from Amazon pose challenges.
Wall Street remains bullish with 16 buy ratings and a $69.33 price target suggesting 41% upside. However, technical indicators signal near-term weakness, and the stock faces execution risks in maintaining growth against industry competition. The upcoming Q2 earnings on August 5 will be critical for validating the positive fundamental trajectory.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About GXO Logistics Inc
GXO is the world's largest pure-play contract logistics provider. It offers cutting-edge supply chain solutions, including automated warehousing and fulfillment, for global blue-chip companies.
Read more on GXO →
